On July 4, 2022, Lexston Life Sciences Corp. closed the transaction. The company issued 18,562,440 units at a purchase price of CAD 0.05 per unit for gross proceeds of CAD 928,122 in the transaction.

The Company has paid CAD 4,480 cash to Haywood Securities Inc and CAD 15,400 to Raymond James Ltd. and issued 89,600 broker's warrants to Haywood Securities Inc. and 308,000 broker's warrants to Raymond James Ltd. as finders' fees. All securities issued pursuant to the Private Placement are subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.